Wall Street News Alert's "stocks to watch" this morning are: Wound
Management Technologies, Inc. (OTCBB: WNDM), Gilead Sciences, Inc.
(NASDAQ: GILD), Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) and
GenVec, Inc. (NASDAQ: GNVC).
Yesterday after the markets closed, Wound Management
Technologies, Inc. (OTCBB: WNDM), issued a press release announcing
that that it has engaged National Investment Banking firm Miller
Tabak & Co., LLC, a twenty-eight year old institutional trading
firm as part of it strategy in accelerating the search for
potential partners that will help grow revenues which are necessary
to execute Wound Managements plans for 2010.
According to Deborah Jenkins Hutchinson, Wound Management
President, "We believe that partnering with Miller Tabak will be a
key relationship to help us identify the partners that will benefit
WMT the most and will help us to reach our strategic goals this
year more quickly." The agreement is performance based.
Since 1982, Miller Tabak has gained tremendous experience and
expertise in stocks and options transactions as well as creating a
vast network using electronic markets and information sources.
Today, MT has the most advanced technology systems available
helping to create proprietary expert strategies, providing clients
with split second accuracy and opportune reactions to market
conditions. Offices in New York, Boston, and San Diego provide them
with a country-wide footprint from which to operate.
The stock closed yesterday at $1.37 a share.
For an in-depth profile of Wound Management Technologies, visit
http://www.wallstreetnewsalert.com/view-company-profiles.php?profile=WNDM_011810.
To receive FREE Mobile Stock Alerts formatted especially for
your cell phone, text the word "press" in the subject line to
68494.
For more information, please visit www.WallStreetNewsAlert.com
and you can also follow Wall Street News Alerts on Twitter at
http://twitter.com/wsna.
Gilead Sciences, Inc. (NASDAQ: GILD) up 0.1% on 9.5 million
shares traded.
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need.
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) up 1.9% on 6.4
million shares traded.
Cyclacel is a biopharmaceutical company dedicated to the
discovery, development and commercialization of novel,
mechanism-targeted drugs to treat human cancers and other serious
disorders.
GenVec, Inc. (NASDAQ: GNVC) down 8.3% on 9.1 million shares
traded.
GenVec, Inc. is a biopharmaceutical company developing novel
therapeutic drugs and vaccines.
Market Commentary:
Oil prices rose modestly, with benchmark crude for February
delivery up 40 cents at $78.40. On Friday, the contract slid $1.39
to settle at $78. The price was down $4.75 for the week after
declining for five straight days.
Let Wall Street News Alert help advertise for your company using
our effective awareness campaigns. If you're interested in telling
your story, we can help. Contact us at
info@wallstreetnewsalert.com.
WSNA's email alert service is free to those investors who sign
up on the WSNA home page. The alert service is designed to notify
investors of often-overlooked stocks. Subscribers are introduced to
Special Situation companies that have the potential of showing
increased activity. The Wall Street News Alert home page has
experienced over 200 million hits. To subscribe to this free
service, visit the Wall Street News Alert home page at
http://www.wallstreetnewsalert.com.
*** It has come to the attention of Wall Street News Alert
(WSNA), that various persons or companies distribute faxes bearing
similar names to Wall Street News Alert. Wall Street News Alert is
not affiliated with faxes bearing names such as: Wall Street Stock
Alert, Wall Street Investor Alert, Wall Street News Alert or any
other fax using various combinations of the generic words Wall
Street.***
Wall Street News Alert is a division of Wall Street Capital
Funding LLC (WSCF). WSCF also maintains a contractual, working
relationship with Stock Market Alerts LLC and its' Wall Street
Enews brand. WSCF is not a registered broker/dealer and may not
sell, offer to sell or offer to buy any security. WSCF profiles are
not a solicitation or recommendation to buy, sell or hold
securities. An offer to buy or sell can be made only with
accompanying disclosure documents from the company offering or
selling securities and only in the states and provinces for which
they are approved. The material in this release is intended to be
strictly informational. The companies that are discussed in this
release have not approved the statements made in this release nor
approved the timing of this release. All statements and expressions
are the sole opinion of WSCF and are subject to change without
notice. Information in this release is derived from a variety of
sources including that company's publicly disseminated information,
third parties and WSCF research. The accuracy or completeness of
the information is not warranted and is only as reliable as the
sources from which it was obtained. WSCF disclaims any and all
liability as to the completeness or accuracy of the information
contained and any omissions of material fact in this release. The
release may contain technical inaccuracies or typographical errors.
It is strongly recommended that any purchase or sale decision be
discussed with a financial adviser, or a broker-dealer, or a member
of any financial regulatory bodies. Investment in the securities of
the companies' discussed in this release is highly speculative and
carries a high degree of risk. WSCF is not liable for any
investment decisions by its readers or subscribers. Investors are
cautioned that they may lose all or a portion of their investment
if they make a purchase in WSCF profiled stocks.
This profile is not without bias, and is a paid release. WSCF
has been compensated for dissemination of company information on
behalf of one or more of the companies mentioned in this release.
For current services performed for Wound Management Technologies,
Inc. (OTCBB: WNDM), WSCF has been compensated Fifteen Thousand
Dollars, by third party, Everest Limited Inc., who are
non-affiliated and may hold a significant position in the stock.
WSCF holds no shares of the stock. WSCF may receive additional
compensation for extension of its services. Any additional
compensation will be disclosed at such time that WSCF is aware of a
client's desire to extend the original services. WSCF may have
received shares of a company profiled in this release prior to the
dissemination of the information in this release. WSCF may
immediately sell some or any shares in a profiled company held by
WSCF and may have previously sold shares in a profiled company held
by WSCF. WSCF's services for a company may cause the company's
stock price to increase, in which event WSCF would make a profit
when it sells its stock in a company. In addition, WSCF's selling
of a company's stock may have a negative effect on the market price
of the stock.
This release contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words
such as "may," "future," "plan" or "planned," "will" or "should,"
"expected," "anticipates," "draft," "eventually" or "projected."
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company's annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and WSCF undertakes no
obligation to update such statements.
Contact: Company: Wall Street News Alert Contact email: Email
Contact URL: http://www.wallstreetnewsalert.com
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Sep 2023 to Sep 2024